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Infection of baboons with herpesvirus papio 2 (HVP-2) produces a disease that is similar to human infection with herpes
simplex viruses (HSV). Molecular characterization of HVP-2 has demonstrated that the virion contains a factor which rapidly
shuts off host cell protein synthesis after infection. Reduction of host cell protein synthesis occurs in parallel with the
degradation of mRNA species. A homolog of the HSV virion host shutoff (vhs) gene was identified by Southern and DNA
sequence analysis. The sequence of the HVP-2 vhs gene homolog had greater than 70% identity with the vhs genes of HSV
1 and 2. Disruption of the HVP-2 vhs open reading frame diminished the ability of the virus to shut off protein synthesis and
degrade cellular mRNA, indicating that this gene was responsible for the vhs activity. The HVP-2 model system provides the
opportunity to study the biological role of vhs in the context of a natural primate host. Further development of this system
will provide a platform for proof-of-concept studies that will test the efficacy of vaccines that utilize vhs-deficient viruses.INTRODUCTION
Herpesvirus papio 2 (HVP-2) infection of baboons rep-
resents a surrogate primate model system to study the
biology of herpes simplex virus (HSV) infection of hu-
mans. HVP-2 is associated with oral and genital lesions
that resemble HSV infections of humans. Male baboons
develop erythema of the penis with papules or pustules
that develop into small ulcerative lesions. Female ba-
boons have been observed with ulcerative lesions on the
vulvar tissues. Juvenile animals were found to have pri-
marily oral lesions (Levin et al., 1988). Acquisition of
genital infection is primarily associated with the onset of
sexual activity in baboons. Furthermore, one study pro-
vided evidence that the virus could spontaneously reac-
tivate from latency, a pattern consistent with HSV infec-
tion of humans (Martino et al., 1998).
Early attempts to characterize virus isolated from in-
fected baboons resulted in designation of the virus as
SA8, a virus first isolated from African green monkeys
(Levin et al., 1988). Subsequent analysis of three viral
glycoprotein genes (glycoproteins B, D, and J) confirmed
that the herpesvirus associated with the baboon disease
was closely related to other members of the alphaher-
pesvirus family (HSV-1, HSV-2, herpes B virus). Although
closely related, the isolates represented a new virus
associated with baboons, which was designated as her-
pesvirus papio 2 (HVP-2) (Eberle et al., 1995). Subse-
quent serological analysis has determined that over 90%33of wild-caught baboons were found to have anti-HVP-2
titers, confirming that baboons are a natural host for
HVP-2 (Eberle et al., 1997).
A hallmark of alphaherpesvirus infection is the shutoff
of host protein synthesis during infection (Fenwick,
1984). Shutoff of host macromolecular synthesis occurs
through two independent mechanisms in HSV-infected
cells. Early phase shutoff is mediated by a 58-kDa phos-
phoprotein encoded by the viral UL41 gene designated
the virion host shutoff (vhs) protein (Read and Frenkel,
1983; Kwong et al., 1988, McGeoch et al., 1988; Read et
al., 1993). During infection, the virion tegument (contain-
ing vhs) is released into the cytoplasm of the host cell.
Cytoplasmic vhs is associated with the degradation of
mRNA (Schek and Bachenheimer, 1985; Kwong and
Frenkel, 1987; Strom and Frenkel, 1987; Oroskar and
Read, 1989). Degradation of cellular mRNA shifts the
translation apparatus from host to viral mRNA and facil-
itates the expression of different classes of viral genes. A
secondary phase shutoff is dependent on the immediate-
early protein ICP27 (Nishioka and Silverstein, 1978; Fen-
wick and Clark, 1982; McMahan and Schaffer, 1990;
Hardwicke and Sandri-Goldin, 1999).
The exact mechanism of vhs activity has not been
determined. Several studies have suggested that vhs is
an endonuclease. First, cytoplasmic extracts prepared
from HSV-infected cells or extracts prepared from HSV
virions contain a vhs-dependent RNase activity (Krikorian
and Read, 1991; Sorenson et al., 1991; Karr and Read,
1999; Zelus et al., 1996). Second, vhs induces cleavage of© 2002 Elsevier Science (USA)
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al., 1999a,b). Antibodies to vhs protein block endo-ribo-
nucleolytic activity in vitro (Zelus et al., 1996). Finally, vhs
has homology to the fen-1 family of endonucleases
(Doherty et al., 1996). In vitro studies have shown that vhs
induces endonucleolytic cleavages which cluster toward
the 5 end of the mRNA (Zelus et al., 1996; Karr and Read,
1999; Elgadi et al., 1999a,b). Interestingly, a recent study
by Lu and co-workers (2001a) using a mutant vhs has
demonstrated that the protein may direct initial cleavage
events and play a role in degradation of mRNA contain-
ing IRES elements.
Two studies have demonstrated the potential role of
cellular factors in vhs function. Expression of vhs in
Saccaromyces cerevisiae did not result in any vhs-de-
pendent endoribonuclease activity (Lu et al., 2001b).
However, activity was detected when the yeast extracts
were mixed with rabbit reticulocyte lysates. These stud-
ies indicated that vhs function is dependent on one or
more mammalian factors. In a second study, Feng and
co-workers (2001) demonstrated that vhs bound to the
human translation initiation factor, eIF4H, in both two-
hybrid and co-immunoprecipitation assays. The results
of these studies suggest that vhs is targeted to regions of
translation initiation through interaction with eIF4H.
Several studies using the mouse model of infection
have demonstrated that vhs is an important virulence
factor. For example, Becker and co-workers (1993) dem-
onstrated that vhs-defective viruses lack intraperitoneal
pathogenicity in newborn mice. Strelow and Leib (1995)
demonstrated that vhs-defective viruses did not grow
efficiently in mouse cornea and brains. Furthermore,
vhs-deficient viruses are not efficient at establishment
and reactivation from latency in mouse trigeminal gan-
glia. The attenuated virulence associated with vhs-defi-
cient viruses makes them attractive vaccine candidates.
Interestingly, mice immunized with an HSV-1 strain defi-
cient in vhs activity are protected against corneal chal-
lenge with virulent HSV-1 in a mouse model of infection
(Walker et al., 1998). These studies have been further
extended in the mouse model to show the enhanced
protection against wild-type HSV challenge in animals
vaccinated with a recombinant HSV-1 with deletions in
both vhs and ICP8 (Geiss et al., 2000).
To develop the HVP-2 model system, we have initiated
a careful comparison of the molecular biology of this
virus relative to human simplex viruses. The results of
the studies presented here have demonstrated that
HVP-2 encodes a virion host shutoff function that is
closely related to the vhs encoded by HSV-1. These
studies further demonstrate the close molecular relation-
ship between HVP-2 and HSV. The HVP-2 model provides
a surrogate system to complement and extend our un-
derstanding of the biology of vhs. Future studies can test
the efficacy of vhs-deficient virus vaccines in the context
of a nonhuman primate system.
RESULTS
HVP-2 infection results in a shutoff of host protein
synthesis
The reduction of host cell protein synthesis is a hall-
mark of herpes simplex virus infection (Fenwick, 1984).
To determine whether host protein synthesis is reduced
during HVP-2 infection, [35S]methionine-labeled extracts
from infected and mock-infected Vero cells were pre-
pared at varying times postinfection and analyzed on
denaturing polyacrylamide gels. Comparison of mock-
and virus-infected extracts revealed that HVP-2 infection
resulted in a dramatic reduction in host cell protein
synthesis as early as 2 h postinfection (Fig. 1A). Host cell
protein synthesis was further reduced at 3 and 4 h
postinfection. The appearance of several new protein
species is likely due to the expression of viral genes as
addition of actinomycin D blocks the appearance of
these bands (data not shown). The inhibition of host
protein synthesis early in HVP-2 infection is similar to the
reduction of protein synthesis observed in HSV-1-in-
fected cells (Fig. 1A).
To determine the species-specificity of the HVP-2 pro-
tein shutoff function, [35S]methionine-labeled extracts
were prepared from baboon, human, and mouse cell
lines 4 h postinfection. Extracts were separated on de-
naturing polyacrylamide gels and visualized by autora-
diography. Examination of the autoradiograms demon-
strated that there was a reduction in host cell protein
synthesis in primary baboon fibroblasts, HepG2, and NIH
3T3 cells (Fig. 1B). The observation that HVP-2 induced a
shutoff of host cell protein synthesis in primary baboon
fibroblasts demonstrates that this process occurs in
cells isolated from the natural host. Therefore, shutoff is
a process that is likely to occur during natural infection
and is not the result of an artifact of Vero cell infection.
Shutoff of host protein synthesis was also observed in
human liver cells (HepG2) and mouse fibroblasts
(NIH3T3). Therefore, the HVP-2 host shutoff function is
active in cell types from different species. This observa-
tion indicates that the shutoff of host protein synthesis by
HVP-2 is likely to proceed by a conserved mechanism
that can function in cells from a variety of species.
Shutoff of protein synthesis is associated with the
HVP-2 virion
The decrease in host cell protein synthesis during
HVP-2 infection could be due to the action of a nascent
viral protein(s), the activity of an induced or activated
cellular protein, or the direct action of a virion protein. To
determine whether the shutoff function is mediated by a
virion-associated factor, Vero cells were treated with
actinomycin D to prevent nascent viral and cellular tran-
scription. Cells were infected at an increasing multiplicity
of infection (m.o.i.) with HVP-2. After 3 h, the cells were
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labeled in media containing [35S]methionine for 1 h, har-
vested, and lysed. The amount of labeled proteins was
quantitated by trichloroacetic acid (TCA) precipitation.
The results of these assays are shown in Fig. 1C. Clearly,
HVP-2 infection effectively inhibited cell protein synthe-
sis in the presence of the transcriptional inhibitor acti-
nomycin D. Furthermore, the effect observed was dos-
age dependent with greater levels of shutoff at 5–10
m.o.i. relative to 1.0 m.o.i. Infection of cells with at a level
of 1.0 m.o.i. resulted in levels of protein synthesis that
were approximately 60% of uninfected levels. Infection
with a higher m.o.i. of virus was associated with an
approximately 90% inhibition of host cell protein synthe-
sis. To confirm that the actinomycin D treatment was
FIG. 1. HVP-2 contains a virion host shutoff activity. (A) Shutoff of host protein synthesis in Vero cells infected with HVP-2 or HSV-1. Cell monolayers
were mock-infected or infected at a multiplicity of infection (m.o.i.) of 10 plaque forming units per cell with HVP-2 strain 860 or HSV-1 strain KOS. One
hour prior to harvest the cells were rinsed with methionine-free minimal essential medium (MEM) and pulse labeled with [35S]methionine. Cells were
harvested at varying times postinfection by addition of SDS-containing lysis buffer. Samples from equivalent numbers of cell were resolved on 4–20%
denaturing polyacrylamide gels and visualized by autoradiography. Note the decrease in number and intensity of protein species relative to the
mock-infected lanes. Hours p.i. represent hours postinfection. The numbers along the left side of the gel correspond to molecular weight in
kiloDaltons. (B) HVP-2 host shutoff activity is not restricted to Vero cells. Primary baboon fibroblasts, HepG2, and 3T3 cells infected with HVP-2. Note
the decrease in number and intensity of protein species relative to the mock-infected lanes. (M) represents mock-infected lane. Hours p.i. represent
hours postinfection. The numbers along the left side of the gel correspond to molecular weight in kiloDaltons. (C) HVP-2 vhs activity is associated
with the virion. Vero cell monolayers were treated with actinomycin D and infected with HVP-2 or mock-infected. Three hours postinfection the
samples were washed and incubated with methionine-free MEM containing [35S]methionine and actinomycin D for 1 h. Cells were scraped into PBS
and lysed by successive freeze-thaw cycles. The amount of labeled protein was quantitated by TCA precipitation and analyzed by liquid scintillation.
Note that the addition of increasing amounts of virus decreases the amount of protein synthesis in the presence of actinomycin D. This indicates that
viral gene expression is not required for shutoff of host protein synthesis and that the virion contains the vhs activity. (D) HVP-2 infection results in
a decrease in levels of cellular mRNA. To determine whether HVP-2 results in a decrease of cellular messages, total RNA was isolated from infected-
and mock-infected Vero cells 4 h postinfection. Equivalent amounts of samples were analyzed by Northern analysis using -actin and GAPDH probes.
The relative levels of 28S rRNA were confirmed by staining gels with ethidium bromide. The Northern blot demonstrates that increasing the m.o.i.
enhances the degradation of both mRNA species. HVP-2 m.o.i. represents the HVP-2 multiplicity of infection.
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effective, equivalent amounts of extracts from mock and
treated cells were resolved on 4–20% SDS–PAGE gels
and visualized by autoradiography. The results demon-
strated that the protein species remained comigrated
with cellular proteins in mock-treated cells and that there
was an absence of proteins that typically appear early
during viral infection (data not shown). Therefore, active
levels of viral gene expression are effectively blocked by
actinomycin D. Inhibition of protein synthesis in the ab-
sence of active transcription indicates that synthesis of
viral gene products is not required for shutoff of host
protein synthesis. Rather, the shutoff activity is brought in
by the infecting virus and is therefore virion-associated.
Furthermore, the magnitude of the decrease in protein
synthesis was related to the amount of input virus, i.e.,
the phenomenon was m.o.i. dependent. These results
indicate that inhibition of host protein synthesis is the
result of a factor that is delivered by the HVP-2 virion and
is not the result of the expression of viral genes. Taken
together, these results clearly demonstrate that HVP-2
contains a virion host shutoff function.
HVP-2 infection induces degradation of host mRNA
Infection of cells with HSV-1 has been shown to in-
duce the degradation of mRNA in a vhs-dependent man-
ner (Kwong and Frenkel, 1987; Oroskar and Read, 1989).
To determine whether HVP-2 infection induces degrada-
tion of host cell mRNA, total RNA was isolated from
infected and mock-infected Vero cells 4 h postinfection.
The levels of specific mRNAs were determined by North-
ern blot analysis using probes for mouse glyceraldehyde
phosphate dehydrogenase (GAPDH) and mouse -actin.
The results of these studies are shown in Fig. 1D. Equiv-
alent amounts of RNA were loaded as demonstrated by
the levels of 28S RNA in ethidium bromide stained gels.
In the case of both GAPDH and -actin probes, the level
of message present at 0.1 m.o.i. was similar to the level
of message present in mock-infected cells. However, as
the multiplicity of infection was increased to 1.0 and 10,
there was a corresponding decrease in the level of
message for both GAPDH and -actin. The levels of the
respective RNA species were quantitated by phospho-
rImager analysis. A 10 m.o.i. infection with HVP-2 re-
sulted in a reduction of GAPDH message to levels of only
20% of the mock-infected samples, while -actin was
reduced to levels of approximately 10% of the mock-
infected samples. Therefore, infection of cells with HVP-2
results in a dose-dependent degradation of host cell
mRNA species, a phenomenon associated with vhs func-
tion in HSV-infected cells.
The HVP-2 genome contains a UL41 homolog
The results of protein synthesis and Northern blot
analysis indicate that HVP-2 may contain a homolog of
the HSV-1 UL41 gene that encodes the vhs protein. The
physical map of the HVP-2 genome is colinear with HSV
(J. E. Bigger and D. W. Martin, unpublished data). DNA
sequence analysis of the ends of a 4-kilobase (kb)
BamHI fragment of HVP-2 strain 860 cloned into pUC19
(pBam20) showed homology to genes that flank UL41, the
HSV genes UL40 and UL42. The entire clone was se-
quenced on both DNA strands. BLAST analysis (Gen-
Bank) of the resulting DNA sequence revealed that
HVP-2 contains a HSV-1 UL41 (vhs gene) homolog. The
sequence of this gene has been deposited in GenBank
(Accession No. AF294581). The open reading frame con-
tains 481 amino acids and would encode a protein with
a calculated molecular weight of 54,216 Da. Figure 2
shows the amino acid sequence of the HVP-2 vhs ho-
molog relative to proteins from HSV-1 strain KOS and
HSV-2 strain 333. HVP-2 vhs shows greater than 70%
similarity with the vhs proteins of HSV-1 and HSV-2.
Previous analyses of the sequences of vhs homologs
from several different alphaherpesviruses have revealed
the existence of four conserved domains across the vhs
protein (Berthomme et al., 1993). These domains are well
conserved within the HVP-2 vhs homolog. Phylogenetic
analysis of the HVP-2 vhs relative to vhs homologs of
other alphaherpesviruses demonstrates that the HVP-2
homolog is most closely related to the vhs proteins of
HSV (Fig. 3). The close relationship between the vhs
genes of HVP-2 and HSV is consistent with previous
studies that demonstrated that HVP-2 is closely related
to HSV (Eberle et al., 1995).
Disruption of the HVP-2 UL41 homolog
A recombinant virus with a disruption in the HVP-2 vhs
gene was constructed to determine whether the vhs
homolog is responsible for the modulation of protein
synthesis in infected cells. The pBam20 clone contains
portions of the UL40 and UL42 open reading frames
(ORF) as well as an intact UL41 ORF (Fig. 4). A reporter
gene cassette was constructed that placed the en-
hanced green fluorescent protein (EGFP) gene under
control of the CMV immediate early promoter. This cas-
sette was cloned into the unique Bsu36I site of pBam20
to generate pBam20-EGFP. The resulting construct had
an insertion of the reporter gene cassette 60 nucleotides
from the amino-terminal end of the UL41 open reading
frame, thereby interrupting the vhs protein between the
alanine and leucine residues at positions 20 and 21. The
pBam20-EGFP insert was transferred into the HVP-2 vhs
gene by marker transfer. EGFP-expressing plaques were
purified three times and the recombinant, HVP-2vhs,
was grown to high titers and analyzed to confirm the vhs
deletion. HVP-2vhs was subsequently rescued by
marker transfer with pBam20, a plasmid that contains a
region of the HVP-2 genome that spans the vhs gene.
The rescue virus is designated HVP-2vhsR.
The structure of the recombinant virus was confirmed
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by Southern blot analysis of viral DNA isolated from
wild-type HVP-2, HVP-2vhs, and HVP-2vhsR. A sche-
matic of the vhs locus is shown in Fig. 4A. The presence
of the EGFP insert in HVP-2vhs was confirmed by
Southern analysis of BamHI-cut DNA hybridized with the
EGFP gene as a probe (Fig. 4B). As expected, neither
wild-type HVP-2 or HVP-2vhsR demonstrated any hy-
bridization to the EGFP probe. The vhs locus was visible
as a 4.1-kb BamHI fragment in wild-type HVP-2 and
HVP-2vhsR DNA by Southern analysis using pBam20
as a probe (Fig. 4B). In contrast, digestion of HVP-2vhs
with BamHI demonstrated that the vhs locus is disrupted
due to a BamHI site donated by the reporter gene cas-
sette, resulting in the generation of 4- and 2.2-kb BamHI
FIG. 2. HVP-2 contains a homolog of the HSV UL41 (vhs) gene. Sequence analysis of a 4-kb BamHI fragment cloned from the HVP-2 genome
revealed the presence of a homolog of the HSV vhs gene. The predicted reading frame of the HVP-2 vhs protein shares a high degree of conservation
with vhs homologs from other alphaherpesviruses. The predicted amino acid sequence of the HVP-2 vhs protein is directly compared with the vhs
proteins of HSV-1 and HSV-2. Dots indicate conserved amino acids. The positions of the Box 1, 2, 3, and 4 regions are indicated. The region important
for VP16 binding in HSV-1 is designated by a bar. Note the high degree of amino acid conservation between the vhs homologs of the respective
viruses.
FIG. 3. Phylogenetic analysis of the HVP-2 vhs protein. Phylogenetic analysis of alphaherpesvirus homologs was performed using Clustal analysis
(DNAStar) to determine the relationship between alphaherpesvirus vhs homologs. Note that the HVP-2 vhs homolog is most closely related to vhs
homologs of HSV-1 and HSV-2.
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bands (Fig. 4B). Taken together, the results of the South-
ern analysis indicate the vhs gene has been successfully
interrupted in HVP-2vhs and successfully restored in
HVP-2vhsR.
HVP-2 vhs activity is not required for in vitro
replication
The results of several experiments demonstrated that
the product of the HVP-2 vhs gene is not required for in
vitro replication. First, the ability to construct HVP-2vhs
in a noncomplementing cell line indicates that this viral
gene is dispensable for growth in vitro. Both wild-type
and mutant viruses generate a vigorous plaque after 3
days. However, the morphology of the plaques generated
by HVP-2vhs differed from the plaques produced by
wild-type HVP-2 and HVP-2vhsR on Vero cells (not
shown). Plaques generated by wild-type HVP-2 and
HVP2vhsR on Vero cells do not typically show a clear
area in the center. In contrast, plaques generated by
HVP-2vhs demonstrate greater cell rounding in the cen-
ter of the plaque which leads to a larger area in the
center of the plaque where cells have detached from the
surface. Second, a plaque yield assay was performed to
compare the relative replication rates between wild-type
HVP-2 and HVP-2vhs. This assay measures the burst
size or number of plaque forming units released per
plaque. The results in both Vero cells and primary ba-
boon fibroblasts demonstrated that disruption of the vhs
locus results in a nearly 2 log reduction in viral replica-
tion (data not shown).
Finally, a single-step growth curve was performed to
quantitate the growth of the HVP-2vhs relative to wild-
type HVP-2. Previous studies have determined that the
HVP-2 growth cycle occurs in approximately 18 h (J. E.
Bigger and D. W. Martin, unpublished data). Vero cells
were infected at a m.o.i. of 2 in duplicate with wild-type
HVP-2, HVP-2vhs, or HVP-2vhsR and harvested at
varying times postinfection. Infected cells were disrupted
by successive freeze-thaw cycles and the levels of in-
fectious virus in the supernatants were determined by
plaque analysis. The results of this analysis demon-
strated that HVP-2vhs replicated with slightly delayed
kinetics relative to wild-type virus (Fig. 5). Comparison of
the replication curves revealed that maximal levels of
HVP-2vhs were approximately 1 log lower than wild-
type virus at 20 h postinfection. Interestingly, the replica-
tion of HVP-2vhsR displayed an intermediate pattern of
replication. Although this virus replicated better than
HVP-2vhs at 20 h postinfection, the rescue virus did not
replicate as well as the wild-type isolate. We hypothesize
that the difference in replication may be due to the effect
FIG. 5. HVP-2 vhs is dispensable for in vitro replication. Analysis of
single-step growth kinetics in Vero cells. Vero cells were infected at 2
PFU/cell and harvested by freeze-thaw at varying times postinfection.
Supernatants were titered on Vero cells. Although the HVP-2 vhs gene
is dispensable for replication in vitro, HVP-2vhs does not replicate as
efficiently as wild-type HVP-2. The replication of the rescue virus,
HVP-2vhsR, displays an intermediate phenotype (see text).
FIG. 4. Construction of HVP-2vhs and HVP-2vhsR. (A) Physical
map of the HVP-2 Bam20 fragment. The relative position of the CMV-
EGFP cassette insertion in the vhs gene locus as well as the size of the
respective restriction fragments are shown. (B) Southern analyses of
wild-type HVP-2, HVP-2vhs (vhs knock-out virus), and HVP-2vhsR
(vhs rescue) were performed to confirm the identity of the recombinant
virus. Orientation of the inserted fragment was confirmed by restriction
and Southern blot analyses. Note that hybridization with a CMV-EGFP
probe produced a positive signal only in HVP-2vhs. Hybridization with
a Bam20 probe further demonstrates the disruption in the vhs locus
relative to wild-type HVP-2 and HVP-2vhsR.
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of multiple rounds of replication acquired during gener-
ation of the knock-out and rescue virus in Vero cells
relative to the original, low-passage wild-type isolate.
Future studies that involve the disruption and rescue of
other HVP-2 gene products will isolate wild-type plaques
in parallel with recombinant viruses to compare the rep-
lication of viruses subjected to equivalent rounds of in
vitro replication. Taken together, these studies demon-
strate that although the vhs gene is dispensable for
HVP-2 replication in vitro, optimal replication requires the
presence of functional HVP-2 vhs. Future studies will test
the role of the HVP-2 vhs gene during in vivo infection. In
vivo studies will require the use of a vhs knock-out virus
that contains a small mutagenesis cassette to avoid any
variables imposed by a large mutagenesis cassette that
encodes a reporter gene.
The HVP-2 UL41 homolog encodes vhs activity
To determine whether disruption of the HVP-2 vhs
locus affects the shutoff of host cell protein synthesis,
infected cells were transiently labeled with [35S]methi-
onine and the extracts were analyzed by SDS–PAGE. The
results of this assay are shown in Fig. 6A. Infection with
wild-type HVP-2 results in a significant decrease in host
cell protein synthesis at 4 h postinfection when com-
pared to the mock-infected samples. Infection with HVP-
2vhs did not result in a significant level of shutoff of
host cell protein synthesis. The slight reduction observed
is most likely the result of the simple competition of viral
and cellular messages for the translation apparatus.
However, the overall distribution of protein synthesis is
very similar to that observed in mock-infected cells. In-
terestingly, the pattern of protein synthesis in HVP-
2vhsR was identical to the pattern observed in cells
infected with wild-type HVP-2. Therefore, the HVP-2 vhs
gene is required for efficient shutoff of host cell protein
synthesis. We have shown earlier that infection of cells
with wild-type HVP-2 induces the degradation of host cell
mRNA (Fig. 1D). Therefore, Northern analysis was per-
formed to determine whether the HVP-2 vhs gene prod-
uct was responsible for the decrease in levels of cellular
mRNA. Total RNA was isolated from cells infected with
wild-type HVP-2, HVP-2vhs, HVP-2vhsR, or mock-in-
fected cells and analyzed to determine the relative levels
of GAPDH and -actin messages by Northern analysis
(Fig. 6B). Infection with both wild-type HVP-2 and HVP-
2vhsR resulted in a significant reduction in the levels of
both -actin and GAPDH mRNA. In contrast, infection
with HVP-2vhs did not cause a significant reduction in
the levels of mRNA and the general levels were similar to
the signals observed in mock-infected cells (Fig. 6B).
Quantitation by phosphorImager analysis revealed that
infection with wild-type HVP-2 and HVP-2vhsR reduced
the -actin mRNA levels to 23 and 10% of mock-infected
levels, respectively. In addition, the GAPDH mRNA levels
were reduced to 12 and 19% the levels of observed in
mock-infected cells. In contrast, cells infected with HVP-
2vhs maintained high levels of -actin mRNA (95%) and
GAPDH mRNA (81%) relative to the levels found in mock-
infected cells. Therefore, these results clearly demon-
strate that the vhs gene is clearly required for both the
shutoff of host protein synthesis and the reduction in
host mRNA levels.
DISCUSSION
The results of these studies have demonstrated that
HVP-2 encodes a virion host shutoff function. First, infec-
tion of cells with HVP-2 resulted in a decrease in host
cell protein synthesis. In addition, the shutoff activity was
associated with the HVP-2 virion. Second, the decrease
in host protein synthesis was accompanied by degrada-
tion of cellular mRNA. Third, analysis of the HVP-2 ge-
nome revealed a homolog of the HSV UL41 (vhs) gene.
The HVP-2 homolog maintains greater than 70% homol-
ogy with the UL41 genes from HSV. Finally, a recombi-
FIG. 6. The HVP-2 vhs gene is essential for shutoff activity. Deletion
of the vhs gene restores host protein synthesis in infected cells. (A)
Analysis of protein synthesis. Vero cells were infected with HVP-2,
HVP-2vhs, HVP-2vhsR, or mock-infected for 4 h. One hour prior to
harvest the cells were radiolabeled with MEM containing [35S]methi-
onine. Cells were harvested in SDS–Tris glycine sample buffer. Equiv-
alent amounts of extract were run on 4–20% SDS–PAGE and visualized
by autoradiography. The gel is representative of two independent
experiments. Numbers along the vertical axis represent the molecular
weight in kiloDaltons. Note that disruption of vhs results in levels of
protein synthesis similar to mock-infected cells and that restoration of
the wild-type vhs gene in HVP-2vhsR generates a pattern of protein
synthesis identical to wild-type HVP-2. (B) Deletion of the vhs gene
restores stability to host mRNA species. Northern analysis of total RNA
extracted from Vero cells infected with wild-type virus, HVP-2vhs,
HVP-2vhsR, or mock-infected 4 h postinfection. Levels of total RNA
were determined by ethidium bromide staining to visualize 28S RNA.
mRNA was detected using mouse probes against -actin and GAPDH.
Note that disruption of the vhs gene reading frame results near wild-
type levels of mRNA and that restoration of the wild-type vhs locus in
HVP-2vhsR results in a reduction of host mRNA as seen in cells
infected with wild-type HVP-2.
39HVP-2 ENCODES A VIRION HOST SHUTOFF FUNCTION
nant virus with a disruption in the HVP-2 vhs gene lost
the ability to shut off host protein synthesis and degrade
cellular mRNA. Subsequent marker transfer of a wild-
type locus back into the virus restored the ability of the
virus to mediate shutoff of host protein synthesis. The
vhs gene was dispensable for in vitro replication, al-
though levels of virus were reduced relative to wild-type
HVP-2. Taken together, these results demonstrate that
HVP-2 encodes a virion host shutoff function that is
closely related to the vhs protein encoded by HSV.
The identification of an HVP-2 vhs homolog is signifi-
cant for several reasons. First, characterization of the vhs
gene of HVP-2 provides further evidence of the close
molecular relationship between HVP-2 and the human
simplex viruses. Second, the identification of a closely
related vhs gene in HVP-2 provides a surrogate primate
system to study the in vitro and in vivo biology of vhs.
Finally, the identification of a vhs homolog in HVP-2 will
provide a proof-of-concept platform allowing for the fur-
ther development of vhs-deficient viruses for use in vac-
cine therapy. The use of a relevant surrogate primate
model to test the efficacy of these novel vaccines strat-
egies should refine the development of these strategies
and extend the results from small animal models of HSV
infection.
The predicted reading frame of the HVP-2 vhs homolog
maintains greater than 70% identity with HSV vhs.
Berthomme et al. (1993) identified four domains of vhs
that were highly conserved among alphaherpesviruses.
These four domains are well conserved in HVP-2 vhs
(Fig. 2). Most cases of divergence within these domains
represent conservative changes. Everly and Read (1999),
using point mutations of HSV-1 vhs/HSV-2 vhs chimeras,
identified a number of residues of HSV-2 vhs (namely,
R19, R22, E25, A396, and S423), which when placed
individually into the HSV 1 vhs background would en-
hance vhs activity. HVP-2 vhs maintains conservation
with HSV-2 vhs at each of these residues with the ex-
ception of positions 25 and 423. HVP-2 vhs substitutes
alanine at position 25 (which is conserved with HSV-1
vhs) and an alanine at position 423. Finally, the sequence
conservation between HVP-2 and HSV vhs proteins sug-
gests that the protein–protein interactions observed with
HSV-1 vhs may be conserved in the HVP-2 system. For
example, HSV-1 vhs has been shown to interact with
VP16 (Smibert et al., 1994). Presumably, this interaction
modulates vhs activity during late times of infection. We
have previously identified a VP16 homolog in HVP-2
(GenBank Accession No. AF294740). Although this prod-
uct has not yet been characterized, it will be interesting
to determine whether the HVP-2 vhs interacts with HVP-2
VP16. The domain where HSV-1 vhs interacts with VP16
has been mapped to amino acids 310–330 (Schmelter et
al., 1996). Interestingly, the homologous domain in HVP-2
vhs (HVP-2 vhs amino acids 294–314) is relatively well
conserved and maintains a tryptophan residue critical for
HSV vhs:VP16 interaction. These similarities, coupled
with the high degree of identity between the HVP-2 VP16
and HSV VP16 proteins (J. E. Bigger and D. W. Martin,
unpublished data), suggest that the HVP-2 vhs may in-
teract with VP16 as well. In addition, recent studies by
Feng and co-workers (2001) have demonstrated that
HSV-1 vhs interacts with eIF4H. Presumably, the interac-
tion of vhs with eIF4H targets vhs to regions of transla-
tion initiation. Future studies will test the hypothesis that
HVP-2 vhs interacts with eIF4H and VP16.
The importance of the vhs protein for the pathogenesis
of the virus has been underscored by a series of studies
on the virulence of HSV deficient for vhs function (Becker
et al., 1993; Strelow and Leib, 1995; Strelow et al., 1997;
Smith et al., 2000, 2002). Basically, these studies have
shown that deletion of vhs function attenuates viral in-
fection and latency in small animal models of disease
presumably due to altered patterns of viral gene expres-
sion. vhs is also likely to play an important role in viral
evasion of the host immune response. Evidence for this
role in immune evasion has been provided by several
studies. First, vhs function has been associated with a
reduction in host cell MHC class I expression which
would be expected to result in a lower degree of pre-
sentation of viral antigen to the immune system (Hill et
al., 1994). The vhs protein of bovine herpes virus 1 has
also been associated with the down-regulation of MHC
class I in infected cells (Koppers-Lalic et al., 2001). Sec-
ond, the vhs protein of HSV-2 has been shown to inhibit
the activity of CD8 CTL clones against HSV-2-infected
fibroblasts (Tigges et al., 1996). Third, using -irradiated
mice, Suzutani and co-workers (2000) demonstrated that
vhs function could inhibit the innate immune response.
Interestingly, deletion of the vhs gene improves the im-
munogenicity of a replication-incompetent vaccine strain
(Geiss et al., 2000). Presumably, increased levels of viral
gene products coupled with enhanced antigen presen-
tation provide more target antigen to the host immune
system. Taken together, it is likely that an additional
function of vhs is to modulate the host immune response
to infection. Future studies are planned to assess the
role of HVP-2 vhs in immune evasion in a primate host.
The potential role of vhs in immune evasion makes
vhs-deficient viruses attractive candidates for vaccine
development. Furthermore, vhs-deficient viruses demon-
strate low levels of pathogenicity in mouse models and
do not establish or reactivate from latency efficiently
(Strelow and Leib, 1995, 1997). Interestingly, a vaccine
strategy that employed a replication-defective virus with
a deletion in ICP8 demonstrated greater levels of efficacy
when an additional mutation was introduced to make the
virus vhs-deficient (Geiss et al., 2000). We have identified
a ICP8 homolog in HVP-2 (J. E. Bigger and D. W. Martin,
unpublished data). Deletion of this gene in the context of
our vhs-deficient virus would make an attractive candi-
date to study the efficacy of this vaccine strategy in the
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context of a primate host. The results of these studies
may further demonstrate that vhs-deficient viruses rep-
resent effective vaccine strategies and lead to future
human trials.
MATERIALS AND METHODS
Cells and virus
Vero and NIH3T3 cells were obtained from the Amer-
ican Type Culture Collection and maintained in Dulbec-
co’s modified essential medium (DMEM) (GIBCO Life
Technologies, Rockville, MD) supplemented with 10%
fetal bovine serum (FBS) (Hyclone) and penicillin and
streptomycin. Primary baboon fibroblasts were obtained
by skin punch biopsy of baboons (Papio anubis) at South-
west Foundation for Biomedical Research under strict
animal welfare standards. Briefly, skin punches  1 cm2
were trypsinized to release fibroblasts from the tissue
matrix and the cells were plated in DMEM with 10% FBS.
Aliquots of low passage cells were frozen at 130°C.
Cells used to detect vhs activity were used at 20
passages. HVP-2 strain 860 was obtained from R. Eberle,
Oklahoma State University, Stillwater, OK. HSV-1 KOS
and HVP-2 were propagated and titered on Vero cells.
Protein analysis
Cells were infected or mock-infected in duplicate at
varying m.o.i. in DMEM with 10% FCS. One hour before
harvesting, monolayers were washed with minimal es-
sential medium (MEM) without methionine or cysteine
(Selectamine, GIBCO). Cultures were then incubated in
MEM (methionine- and cysteine-free) containing 0.1
Ci/ml EasyTag Express protein labeling mix ([35S]-me-
thionine and -cysteine, NEN Life Science Products, Bos-
ton, MA). For SDS–PAGE analysis, cells were lysed di-
rectly with Tris–glycine sample buffer (Novex) containing
2-mercaptoethanol and heated at 100°C for 5 min. Equiv-
alent amounts of extract were run on 4–20% Tris–glycine
gels (Novex). The levels of protein synthesis were visu-
alized by autoradiography. To determine the role of the
virion in vhs function, Vero cells were treated with 40
g/ml actinomycin D (Sigma) to inhibit transcription dur-
ing the course of the infection. To quantitate the amount
of labeled protein, duplicate infected and mock-infected
samples were scraped into phosphate-buffered saline
(PBS) and subjected to three freeze-thaw samples from
70°C to 37°C. Equivalent amounts of extract were
precipitated with 10% trichloroacetic acid (TCA) in the
presence of 100 g/ml bovine serum albumin (BSA). Acid
precipitable counts were collected by filtration through
0.45-m glass wool filters and quantitated by liquid scin-
tillation counting.
Northern analysis
Vero cells were infected or mock-infected at varying
m.o.i. for 4 h. RNA was isolated using the RNeasy mini-
prep (Qiagen, Valencia, CA) and quantitated on a DU-68
spectrophotometer (Beckman). Two to four micrograms
of RNA were resolved by formaldehyde-agarose gel elec-
trophoresis and Northern blotted using materials from
the NorthenMax blotting system (Ambion, Austin, TX).
Blots were hybridized with random-prime labeled mouse
-actin or GAPDH (Ambion). The level of specific mes-
sage was determined by autoradiography and quanti-
tated by phosphorImager analysis (Molecular Dynamics
phosphorImager 445SI).
Sequence alignments
Sequence alignments and phylogenetic tree were con-
ducted using the Megalign program (DNAStar, Madison,
WI). A phylogenetic tree was constructed using the
Clustal method of alignment with PAM250 residue
weight table. Accession numbers of protein sequences
from GenBank are as follows: HSV-1 KOS (AF007815),
HSV-2 strain 333 (AF007816), BHV-1.1 (AJ004801), EHV-1
(M86664), PrV (S57917), GHV-2 (L40429), GHV-1 (AF168792),
VZV strain Dumas (P09275), and HVP-2 strain 860
(AAG01880).
Generation of HVP-2vhs and HVP-2vhsR
Disruption of the HVP-2 vhs gene was accomplished
by marker transfer. Briefly, the HVP-2 UL41 (vhs) homolog
was isolated on a 4-kb BamHI clone (pBam20). The gene
encoding the EGFP from the vector pEGFP-N1 (Clontech)
was cloned by PCR downstream of the human cytomeg-
alovirus (CMV) immediate-early promoter in the pCI ex-
pression vector (Promega, Madison, WI) using the re-
striction sites NheI and EcoRI to generate pCI-EGFP. The
CMV-EGFP was PCR amplified using primers containing
Bsu36I restriction sites at the termini so that the product
could be cloned into the unique Bsu36I restriction site of
pBam20 to generate pBam20-EGFP. The insertion of this
fragment into the vhs gene interrupts the vhs open read-
ing frame 60 nucleotides from the amino-terminal end of
the UL41 open reading frame, thereby interrupting the
vhs protein between the alanine and leucine residues at
positions 20 and 21. pBam20-EGFP was transfected with
wild-type HVP-2 strain 860 DNA into Vero cells. Recom-
binant virus plaques were selected by EGFP expression
under fluorescent microscopy. The virus was plaque pu-
rified three times. Virus stocks were prepared by low
multiplicity of infection passage on Vero cells. Marker
transfer was used to rescue the CMV-EGFP insert from
the HVP-2 vhs gene. HVP-2vhs DNA was cotransfected
into Vero cells with pBam20. Plaques that did not exhibit
EGFP expression using fluorescent microscopy were
identified, picked, and subsequently plaque-purified
three times. The resulting virus was designated HVP-
2vhsR and was grown to high titer on Vero cells. The
identity of the respective viruses was confirmed relative
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to wild-type virus by Southern analysis using probes
specific for the vhs homolog and EGFP genes.
Characterization of HVP-2vhs growth in vitro
Plaque morphology was assessed on Vero cells with
an overlay of DMEM/5% fetal calf serum/1% methyl cel-
lulose at 2–3 days postinfection. Plaques were visualized
on an Olympus CK2 microscope. Single-step growth
curves were performed in duplicate on Vero cells. Briefly,
1  105 cells in 24-well dishes (Falcon) were inoculated
with two plaque forming units per cell of wild-type or
mutant virus in 200 l of media and incubated at 37°C for
1 h. The infectious inoculum was aspirated and replaced
with 1 ml of complete growth media (DMEM with 10%
fetal bovine serum). At varying times postinfection sam-
ples were frozen at 70°C. Samples were thawed
quickly to release infectious virus and subjected to a
low-speed centrifugation to remove cellular debris. Ali-
quots of cleared supernatant were assayed for the pres-
ence of infectious virus by standard plaque assay on
Vero cells. Determination of burst size (number of plaque
forming units released per plaque) was determined on
Vero cells and primary baboon fibroblasts. Briefly, cells
were infected in quadruplicate on six-well dishes with
increasing dilutions of virus. The virus was allowed to
adhere for 1 h at 37°C. The inoculum was removed and
replaced with complete growth medium (two wells) or
growth medium plus methyl cellulose (two wells). After
plaques were fully formed at 3–4 days postinfection, the
number of plaques per well was determined from the
samples containing the methyl cellulose overlay. The
corresponding plates under DMEM were frozen and
thawed, and the debris was pelleted by low-speed cen-
trifugation. The number of plaque forming units in the
supernatant was determined by standard plaque assay
on Vero cells. The number of plaque forming units per
original plaque was determined by comparing the yield
with the number of plaques counted for the respective
dilution relative to the number of plaques originally
counted on the first series of dilutions plated under
methyl cellulose.
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Note added in proof. During the publication of this manuscript Everly
et al. (J. Virol. 76, 8560–8571, 2002) have provided additional evidence
that the Vhs protein is a nuclease. In addition, Keadle et al. (J. Gen.
Virol. 83, 2361–2365, 2002 and J. Virol. 76, 3615–3625, 2002) have
demonstrated that vhs-deficient viruses are effective therapeutic vac-
cines in a mouse model of ocular infection.
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